Hamps Bio Limited (BOM:544312)
India
· Delayed Price · Currency is INR 42.75
0.00 (0.00%)
At close: May 7, 2025
Hamps Bio Revenue
In the fiscal year ending March 31, 2024, Hamps Bio had annual revenue of 64.75M INR with 16.08% growth.
Revenue
64.75M
Revenue Growth
+16.08%
P/S Ratio
3.20
Revenue / Employee
887.03K
Employees
73
Market Cap
206.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 64.75M | 8.97M | 16.08% |
| Mar 31, 2023 | 55.78M | 2.38M | 4.45% |
| Mar 31, 2022 | 53.40M | 15.18M | 39.71% |
| Mar 31, 2021 | 38.22M | -8.20M | -17.67% |
| Mar 31, 2020 | 46.43M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Bajaj Finance | 369.88B |